期刊文献+

恶性血液病合并侵袭性肺真菌感染52例临床分析 被引量:4

Clinical analysis of 52 cases of hematological malignancies with invasive pulmonary fungal infection
下载PDF
导出
摘要 目的:进一步提高临床医生对恶性血液病合并侵袭性肺真菌感染的认识,改进治疗措施,减少侵袭性肺真菌感染率、死亡率,提高生存率。方法:分析住院的恶性血液病合并肺侵袭性真菌感染患者52例的一般临床资料、微生物学检查及治疗情况。结果:侵袭性肺真菌感染的发病率不断增高,病原菌以念珠菌为主,52例患者应用抗真菌药物后总有效率为59.6%,死于真菌感染患者19例,死亡率为36.5%。结论:侵袭性肺真菌感染是恶性血液病患者化疗期间严重的并发症和主要的死亡原因之一,早期诊断及经验治疗具有重要意义。 Objective To improve the comprehension of motivation of hematological malignancies accompanied with invasive pulmonary fungal infection, to improve therapeutic measure, reduce fungal infection, mortality rate and increase survival rate. Method Retrospective study of the fungous infection table, nlicrobiology, treatment and outcome of 52 cases who had be clearly diagnosed as hematological malignancies accompanied invasive pulmonary fungal infection. Results Invasive pulmonary fungal infections continued to increase in the incidence,the most commen fungus was C andida,52 patients after application of antifungal agents had a total efficiency of 59. 6% , 19 patients died of fungal infection,and mortality rate was 36.5%. Conclusion Invasive pulmonary fungal infections in patients with hematological malignancies during chemotherapy are important complications and the mainly cause of death. Early diagnosis and empirical treatment is very importance.
出处 《吉林医学》 CAS 2010年第1期20-21,共2页 Jilin Medical Journal
关键词 恶性血液病 真菌 Hematological malignancies Fungal infection Pulmonary
  • 相关文献

参考文献7

二级参考文献15

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 2李仲兴 郑家齐.诊断细菌学[M].香港:黄河文化出版社,1992.295-297. 被引量:263
  • 3[2]Knaus WA,Draper EA,Wagner DP,et al. APACHEⅡ:a severity of disease classification system[J]. Crit care Med,1985,13(10):818-829 被引量:1
  • 4[6]Colombo Al. Epidemiology and treatment of hematogenous candidiasis:a Brazilian Spective Braz[J]. Infect Dis. 2000,4(3):113-118 被引量:1
  • 5Louie A,Antimicrob Agents Chemother,1999年,43卷,2831页 被引量:1
  • 6Stevens DA,Kan VL,Judson MA,et al.Practice guidelines for diseases caused by Aspergillus.Infectious Diseases Society of America.Clin Infect Dis,2000,30:696-709. 被引量:1
  • 7Ascioglu S,Rex JH,de Pauw B,et al.Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus.Clin Infect Dis,2002,34:7-14. 被引量:1
  • 8Denning DW,Kibbler CC,Barnes RA,et al.British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections.Lancet Infect Dis,2003,3:230-240. 被引量:1
  • 9Pappas PG,Rex JH,Sobel JD,et al.Guidelines for treatment of candidiasis.Clin Infect Dis,2004,38:161-189. 被引量:1
  • 10Slavin MA,Szer J,Grigg AP,et al.Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections.Intern Med J,2004,34:192-200. 被引量:1

共引文献1040

同被引文献60

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部